Voyager Therapeutics
VYGR
VYGR
101 hedge funds and large institutions have $130M invested in Voyager Therapeutics in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.22% less ownership
Funds ownership: 73.9% → 71.68% (-2.2%)
34% less capital invested
Capital invested by funds: $198M → $130M (-$68.1M)
82% less call options, than puts
Call options by funds: $300K | Put options by funds: $1.62M
Holders
101
Holding in Top 10
1
Calls
$300K
Puts
$1.62M
Top Buyers
| 1 | +$4.16M | |
| 2 | +$3.47M | |
| 3 | +$2.13M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.83M |
| 5 |
Two Sigma Investments
New York
|
+$1.54M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$2.78M | |
| 3 | -$1.91M | |
| 4 |
Morgan Stanley
New York
|
-$1.19M |
| 5 |
Goldman Sachs
New York
|
-$1.08M |